Osiyemi O, De Wit S, Ajana F, Bisshop F, et al. Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) Versus
Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of
Virologic Suppression in Adults Living With HIV-1: Results Through Week 144 From
the Phase 3, Clin Infect Dis 2022 Jan 25. pii: 6515475. doi: 10.1093.
PMID: 35079789